AIDX

20/20 Biolabs, Inc. Common Stock

0.23

USD

0.00

-1.15%

Oct 26, 15:40 UTC -4

Closed

Pre-Market

0.24

+0.01

+3.66%

20/20 Biolabs, Inc. Common Stock (AIDX) Earnings

AIDX Earnings Reports

Positive Surprise Ratio

AIDX beat 0 of 1 last estimates.

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

20/20 Biolabs, Inc. Common Stock earnings per share and revenue

On Aug 14, 2026, AIDX reported earnings of -0.25 USD per share (EPS) for Q2 26, missing the estimate of -0.12 USD, resulting in a -104.25% surprise. Revenue reached 731.00 thousand, compared to an expected 648.72 thousand, with a 12.68% difference. The market reacted with a +0.24% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Danaher Corporation

Report Date

Oct 21, 2026 For Q3 26

Estimate

$1.93

Actual

$2.11

Surprise

+8.99%

HCA Healthcare, Inc.

Report Date

Oct 27, 2026 For Q3 26

Estimate

$6.72

Actual

$7.22

Surprise

+7.29%

Elevance Health, Inc.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$4.72

Actual

$6.99

Surprise

+47.81%

Medpace Holdings, Inc. Common Stock

Report Date

Oct 21, 2026 For Q3 26

Estimate

$4.52

Actual

$4.84

Surprise

+6.98%

FAQ

What were 20/20 Biolabs, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, 20/20 Biolabs, Inc. Common Stock reported EPS of -$0.25, missing estimates by -104.25%, and revenue of $731.00K, 12.68% above expectations.

How did the market react to 20/20 Biolabs, Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 0.24%, changed from $0.55 before the earnings release to $0.55 the day after.

When is 20/20 Biolabs, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for 20/20 Biolabs, Inc. Common Stock's next earnings report?

Based on -- analysts, 20/20 Biolabs, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.